Lower-grade gliomas: The wrong target for bevacizumab

David Schiff; John F. De Groot

doi:10.1093/neuonc/noy165

Lower-grade gliomas: The wrong target for bevacizumab

David Schiff, John F. De Groot

Neuro-Oncology

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	1559-1560
Number of pages	2
Journal	Neuro-oncology
Volume	20
Issue number	12
DOIs	https://doi.org/10.1093/neuonc/noy165
State	Published - Nov 12 2018

ASJC Scopus subject areas

Oncology
Clinical Neurology
Cancer Research

Access to Document

10.1093/neuonc/noy165

Cite this

@article{374722f17349400cb2b78715a1141a14,

title = "Lower-grade gliomas: The wrong target for bevacizumab",

author = "David Schiff and {De Groot}, {John F.}",

year = "2018",

month = nov,

day = "12",

doi = "10.1093/neuonc/noy165",

language = "English (US)",

volume = "20",

pages = "1559--1560",

journal = "Neuro-oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Lower-grade gliomas

T2 - The wrong target for bevacizumab

AU - Schiff, David

AU - De Groot, John F.

PY - 2018/11/12

Y1 - 2018/11/12

UR - http://www.scopus.com/inward/record.url?scp=85056351490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056351490&partnerID=8YFLogxK

U2 - 10.1093/neuonc/noy165

DO - 10.1093/neuonc/noy165

M3 - Editorial

C2 - 30418659

AN - SCOPUS:85056351490

SN - 1522-8517

VL - 20

SP - 1559

EP - 1560

JO - Neuro-oncology

JF - Neuro-oncology

IS - 12

ER -

Lower-grade gliomas: The wrong target for bevacizumab

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this